Caring Brands, Inc. (CABR)
NASDAQ: CABR · Real-Time Price · USD
1.220
+0.070 (6.09%)
At close: Jun 26, 2026, 4:00 PM EDT
1.210
-0.010 (-0.82%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Company Description
Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products.
It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; and CB-101 (Eczema Treatment) for atopic dermatitis (eczema).
The company also offers NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics, as well as provides vitiligo solutions and women’s sexual wellness products.
Caring Brands, Inc., was incorporated in 2020 and is based in Fort Pierce, Florida.
Caring Brands, Inc.
| Country | United States |
| Founded | 2020 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Glynn Wilson |
Contact Details
Address: 130 S Indian River Drive, Suite 202 Fort Pierce, Florida 34950 United States | |
| Phone | (561) 896-7616 |
| Website | Caringbrands.com |
Stock Details
| Ticker Symbol | CABR |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002020737 |
| CUSIP Number | 14216J109 |
| ISIN Number | US14216J1097 |
| Employer ID | 99-4103908 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Dr. Glynn Wilson Ph.D. | Chief Executive Officer and Director |
| Brian Scott John | Founder, Interim Chief Financial Officer and Chief Investment Officer, Principal Accounting Officer & Executive Chairman |
| Paul Jones | Operations Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 1, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 1, 2026 | 8-K | Current Report |
| May 29, 2026 | 8-K | Current Report |
| May 27, 2026 | DEF 14A | Other definitive proxy statements |
| May 15, 2026 | PRE 14A | Other preliminary proxy statements |
| May 14, 2026 | EFFECT | Notice of Effectiveness |
| May 12, 2026 | 10-Q | Quarterly Report |
| May 12, 2026 | UPLOAD | Filing |
| May 7, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 6, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |